Insider Trading activities of Fulgent Genetics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Fulgent Genetics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Fulgent Genetics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Fulgent Genetics, Inc. since 2005. The reporting company's ticker symbol is FLGT. The reporting company's CIK number is 1674930.
The total value of stock buying since 2005 is $9,558,587.
The total value of stock sales since 2005 is $3,062,400.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Fulgent Genetics, Inc. (FLGT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-03 8,739 $43,240 1,165 $5,440 0 $0
2018-11 20,880 $72,647 1,446 $5,062 0 $0
2018-08 0 $0 1,405 $6,322 0 $0
2018-05 0 $0 1,370 $5,096 0 $0
2018-03 0 $0 1,628 $6,121 0 $0
2017-11 56,763 $188,074 1,573 $5,065 0 $0
2017-08 0 $0 6,134 $35,019 0 $0
2017-06 50,000 $254,626 0 $0 0 $0
2016-09 1,000,000 $9,000,000 0 $0 0 $0
2016-05 0 $0 2,565,789 $2,994,275 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Fulgent Genetics, Inc. insiders (FLGT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-03-05 Hsieh Ming (President and CEO) Buy 8,739 4.95 43,240
2019-03-05 Kim Paul (CFO and Treasurer) Sale 1,165 4.67 5,440
2018-11-13 Hsieh Ming (President and CEO) Buy 10,880 3.59 39,037
2018-11-13 Kim Paul (CFO and Treasurer) Sale 1,446 3.50 5,062
2018-11-09 Hsieh Ming (President and CEO) Buy 10,000 3.36 33,610
2018-08-13 Kim Paul (CFO and Treasurer) Sale 1,405 4.50 6,322
2018-05-14 Kim Paul (CFO and Treasurer) Sale 1,370 3.72 5,096
2018-03-08 Kim Paul (CFO and Treasurer) Sale 1,628 3.76 6,121
2017-11-30 Hsieh Ming (President and CEO) Buy 2,000 3.60 7,208
2017-11-21 Hsieh Ming (President and CEO) Buy 1,599 3.12 4,996
2017-11-20 Hsieh Ming (President and CEO) Buy 7,259 3.28 23,809
2017-11-17 Hsieh Ming (President and CEO) Buy 12,291 3.16 38,864
2017-11-16 Hsieh Ming (President and CEO) Buy 1,905 3.22 6,136
2017-11-15 Hsieh Ming (President and CEO) Buy 300 3.28 984
2017-11-14 Hsieh Ming (President and CEO) Buy 2,800 3.35 9,374
2017-11-13 Hsieh Ming (President and CEO) Buy 7,704 3.28 25,269
2017-11-13 Kim Paul (CFO and Treasurer) Sale 1,573 3.22 5,065
2017-11-10 Hsieh Ming (President and CEO) Buy 9,385 3.35 31,402
2017-11-09 Hsieh Ming (President and CEO) Buy 11,520 3.48 40,032
2017-08-11 Kim Paul (CFO and Treasurer) Sale 6,134 5.71 35,019
2017-06-15 Hsieh Ming (President and CEO) Buy 12,700 5.35 67,945
2017-06-14 Hsieh Ming (President and CEO) Buy 7,300 5.11 37,281
2017-06-13 Hsieh Ming (President and CEO) Buy 15,000 5.01 75,195
2017-06-12 Hsieh Ming (President and CEO) Buy 15,000 4.95 74,205
2016-09-30 Hsieh Ming (President and CEO) Buy 1,000,000 9.00 9,000,000
2016-05-13 Gao Hanlin (Chief Scientific Officer) Sale 2,565,789 1.17 2,994,275

Insider trading activities including stock purchases, stock sales, and option exercises of FLGT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Fulgent Genetics, Inc. (symbol FLGT, CIK number 1674930) see the Securities and Exchange Commission (SEC) website.